ASHLI BOWLING: Open Payments
NPI 1710429113 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 40 payments from 12 companies in 2025. Trend: 2023 $723 · 2024 $1,127 · 2025 $873
Food & beverage: $857Education: $16
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $328 |
| Calliditas Therapeutics US Inc. | 6 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| Vifor Pharma, Inc. | 3 | $98 |
| Lilly USA, LLC | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Travere Therapeutics, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $25 |
| Ardelyx, Inc. | 1 | $21 |
| Ascendis Pharma Endocrinology Inc | 1 | $16 |
Products named: Kerendia, TARPEYO, Veltassa, JYNARQUE, JARDIANCE, VOYXACT, Ozempic, IBSRELA.
Industry payments across KY — which companies pay providers there.
